Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: A randomised controlled trial

Thorax

Volumn 65, Issue 1, 2010, Pages 7-13

  Van Wetering, C R ^a   Hoogendoorn, M ^b   Mol, S J M ^a   Rutten Van Molken M P M H ^b   Schols, A M ^c  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PREDNISOLONE;

AGED; AIRWAY OBSTRUCTION; ARTICLE; CAREGIVER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMMUNITY PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DYSPNEA; ENDURANCE; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HAND GRIP; HEALTH PROGRAM; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; SKELETAL MUSCLE; THERAPY EFFECT; TREATMENT OUTCOME; WALKING; WORKLOAD;

EID: 73449124097     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2009.118620     Document Type: Article

References (34)

1. Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 2000;109:207-12.
2. Lacasse Y, Martin S, Lasserson TJ, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys 2007;43:475-85.
3. Guell R, Casan P, Belda J, et al. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 2000;117:976-83.
4. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390-413.
5. Hoogendoorn M, Feenstra TL, Schermer TR, et al. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. Respir Med 2006;100:83-6.
6. Global Initiative for Chronic Obstructive Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2007. http://www.goldcopd.org.
7. Pitta F, Troosters T, Spruit M, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972-7.
8. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83.
9. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-9.
10. Van Wetering CR, Van Nooten FE, Mol SJM, et al. Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Int J COPD 2008;3:443-51.
11. Jones NL, Makrides L, Hitchcock C, et al. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985;131:700-8.
12. Christenhusz L, Pieterse M, Seydel E, et al. Prospective determinants of smoking cessation in COPD patients within a high intensity or a brief counseling intervention. Patient Educ Couns 2007;66:162-6.
13. Broekhuizen R, Wouters EF, Creutzberg EC, et al. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax 2005;60:376-82.
14. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
15. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005;2:75-9.
16. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6.
17. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969;99:696- 702.
18. Schols AM, Wouters EF, Soeters PB, et al. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991;53:421-4.
19. Scott CS, Walker P, Calverley PMA. COPD exacerbations. 4: Prevention. Thorax 2006;61:440-7.
20. Monninkhof E, van der Valk P, van der Palen J, et al. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J 2003;22:815-20
21. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007;370:786-96.
22. Wijkstra PJ, Strijbos JH, Koeter GH. Home-based rehabilitation for patients with COPD: organization, effects and financial implications. Monaldi Arch Chest Dis 2000;55:130-4.
23. Strijbos JH, Postma DS, van Altena R, et al. A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD. A follow-up of 18 months. Chest 1996;109:366-72.
24. Man WD, Polkey MI, Donaldson N, et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004;329:1209.
25. Maltais F, Bourbeau J, Shapiro S, et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2008;149:869-78.
26. Cambach W, Chadwick-Straver RV, Wagenaar RC, et al. The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J 1997;10:104-13.
27. Hoogendoorn M, van Wetering CR, Schols AM, et al. Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Eur Respir J 2009 Jul 2 [Epub ahead of print].
28. Donesky-Cuenco D, Janson S, Neuhaus J, et al. Adherence to a home-walking prescription in patients with chronic obstructive pulmonary disease. Heart Lung 2007;36:348-63.
29. Kahn EB, Ramsey LT, Brownson RC, et al. The effectiveness of interventions to increase physical activity. A systematic review. Am J Prev Med 2002;22(4 Suppl):73-107.
30. Dunn AL, Marcus BH, Kampert JB, et al. Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial. JAMA 1999;281:327- 34.
31. Laviolette L, Bourbeau J, Bernard S, et al. Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax 2008;63:115-21.
32. Casaburi R. Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions. COPD 2005;2:131-6
33. Palange P, Ward SA, Carlsen KH, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007;29:185-209.
34. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am Respir Crit Care Med 2005;171:972-7.